Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking it out: new program aims to boost med adherence in schizophrenia

NCT ID NCT07165821

Disease control Sponsor: Suranaree University of Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether a training program that teaches interpersonal communication skills can improve how consistently people with schizophrenia take their medication. Forty male patients with a history of stopping their meds were split into two groups: one received the training plus usual care, the other only usual care. Researchers measured medication adherence before, right after, and one month after the program. The goal is to see if better communication skills help patients stick to their treatment plan.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Interpersonal Communication Skills Training Program (behavioral intervention)
What this could lead to
If it works, this program could help people with schizophrenia stick to their medication routine, reducing relapses and hospital stays.
What could go wrong
This is a small, completed study with only 40 participants. The results may not apply to everyone, and the program's long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Jun 2024

Finished

Sep 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 59 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male patients aged 20-59 with an ICD-10 schizophrenia diagnosis(F20.0-F20.9). 2. History of psychiatric readmission due to medication non-adherence 3. Mild psychiatric symptoms(Thai BPRS score ≤ 36). 4. Poor interpersonal communication skills(score ≤ 1.50 on Thiengviriya et al.'s assessment tool 5. Low to moderate medication adherence(score ≤ 42 on Uthaiphan \& Daengdomyut's scale 6. Able to read, write, speak, and without hearing/visual impairments. 7. Had a primary caregiver post-discharge. 8. Provided informed consent voluntarily. Exclusion Criteria: Patients with other psychiatric comorbidities(e.g., depression, bipolar disorder, anxiety, or substance-induced psychosis)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Non-adherence, medication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Medication Adherence Psychotic Disorders schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Non-adherence, medication Remission Schizophrenia; psychosis

Contacts and locations

Locations

  • Prasrimahabhodi Psychiatric Hospital, ,Thailand

    Nai Muang, Changwat Ubon Ratchathani, 34000, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.